246 related articles for article (PubMed ID: 32117268)
1.
Villeret B; Solhonne B; Straube M; Lemaire F; Cazes A; Garcia-Verdugo I; Sallenave JM
Front Immunol; 2020; 11():117. PubMed ID: 32117268
[TBL] [Abstract][Full Text] [Related]
2. Influenza-induced type I interferon enhances susceptibility to gram-negative and gram-positive bacterial pneumonia in mice.
Lee B; Robinson KM; McHugh KJ; Scheller EV; Mandalapu S; Chen C; Di YP; Clay ME; Enelow RI; Dubin PJ; Alcorn JF
Am J Physiol Lung Cell Mol Physiol; 2015 Jul; 309(2):L158-67. PubMed ID: 26001778
[TBL] [Abstract][Full Text] [Related]
3. GP96 Drives Exacerbation of Secondary Bacterial Pneumonia following Influenza A Virus Infection.
Sumitomo T; Nakata M; Nagase S; Takahara Y; Honda-Ogawa M; Mori Y; Akamatsu Y; Yamaguchi M; Okamoto S; Kawabata S
mBio; 2021 Jun; 12(3):e0326920. PubMed ID: 34061598
[TBL] [Abstract][Full Text] [Related]
4. IFNAR2 Is Required for Anti-influenza Immunity and Alters Susceptibility to Post-influenza Bacterial Superinfections.
Shepardson KM; Larson K; Johns LL; Stanek K; Cho H; Wellham J; Henderson H; Rynda-Apple A
Front Immunol; 2018; 9():2589. PubMed ID: 30473701
[TBL] [Abstract][Full Text] [Related]
5. Cysteinyl Maresins Reprogram Macrophages to Protect Mice from Streptococcus pneumoniae after Influenza A Virus Infection.
P Tavares L; Brüggemann TR; M Rezende R; G Machado M; Cagnina RE; Shay AE; C Garcia C; Nijmeh J; M Teixeira M; Levy BD
mBio; 2022 Aug; 13(4):e0126722. PubMed ID: 35913160
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-22 reduces lung inflammation during influenza A virus infection and protects against secondary bacterial infection.
Ivanov S; Renneson J; Fontaine J; Barthelemy A; Paget C; Fernandez EM; Blanc F; De Trez C; Van Maele L; Dumoutier L; Huerre MR; Eberl G; Si-Tahar M; Gosset P; Renauld JC; Sirard JC; Faveeuw C; Trottein F
J Virol; 2013 Jun; 87(12):6911-24. PubMed ID: 23596287
[TBL] [Abstract][Full Text] [Related]
7. Coinfection With Influenza A Virus and
Lee KM; Morris-Love J; Cabral DJ; Belenky P; Opal SM; Jamieson AM
Front Immunol; 2018; 9():2377. PubMed ID: 30420852
[TBL] [Abstract][Full Text] [Related]
8.
Saint-Criq V; Villeret B; Bastaert F; Kheir S; Hatton A; Cazes A; Xing Z; Sermet-Gaudelus I; Garcia-Verdugo I; Edelman A; Sallenave JM
Thorax; 2018 Jan; 73(1):49-61. PubMed ID: 28790180
[TBL] [Abstract][Full Text] [Related]
9. Co-infection of H9N2 influenza virus and Pseudomonas aeruginosa contributes to the development of hemorrhagic pneumonia in mink.
Bo-Shun Z; Li LJ; Qian Z; Zhen W; Peng Y; Guo-Dong Z; Wen-Jian S; Xue-Fei C; Jiang S; Zhi-Jing X
Vet Microbiol; 2020 Jan; 240():108542. PubMed ID: 31902499
[TBL] [Abstract][Full Text] [Related]
10. Differential Type I Interferon Signaling Is a Master Regulator of Susceptibility to Postinfluenza Bacterial Superinfection.
Shepardson KM; Larson K; Morton RV; Prigge JR; Schmidt EE; Huber VC; Rynda-Apple A
mBio; 2016 May; 7(3):. PubMed ID: 27143388
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase-9 deficiency protects mice from severe influenza A viral infection.
Rojas-Quintero J; Wang X; Tipper J; Burkett PR; Zuñiga J; Ashtekar AR; Polverino F; Rout A; Yambayev I; Hernández C; Jimenez L; Ramírez G; Harrod KS; Owen CA
JCI Insight; 2018 Dec; 3(24):. PubMed ID: 30568032
[TBL] [Abstract][Full Text] [Related]
12. Influenza A Virus as a Predisposing Factor for Cryptococcosis.
Oliveira LVN; Costa MC; Magalhães TFF; Bastos RW; Santos PC; Carneiro HCS; Ribeiro NQ; Ferreira GF; Ribeiro LS; Gonçalves APF; Fagundes CT; Pascoal-Xavier MA; Djordjevic JT; Sorrell TC; Souza DG; Machado AMV; Santos DA
Front Cell Infect Microbiol; 2017; 7():419. PubMed ID: 29018774
[TBL] [Abstract][Full Text] [Related]
13.
Brao KJ; Wille BP; Lieberman J; Ernst RK; Shirtliff ME; Harro JM
Infect Immun; 2020 Aug; 88(9):. PubMed ID: 32631918
[TBL] [Abstract][Full Text] [Related]
14. Influenza viral neuraminidase primes bacterial coinfection through TGF-β-mediated expression of host cell receptors.
Li N; Ren A; Wang X; Fan X; Zhao Y; Gao GF; Cleary P; Wang B
Proc Natl Acad Sci U S A; 2015 Jan; 112(1):238-43. PubMed ID: 25535343
[TBL] [Abstract][Full Text] [Related]
15. Direct interaction of whole-inactivated influenza A and pneumococcal vaccines enhances influenza-specific immunity.
David SC; Norton T; Tyllis T; Wilson JJ; Singleton EV; Laan Z; Davies J; Hirst TR; Comerford I; McColl SR; Paton JC; Alsharifi M
Nat Microbiol; 2019 Aug; 4(8):1316-1327. PubMed ID: 31110357
[TBL] [Abstract][Full Text] [Related]
16. IL-6-elafin genetically modified macrophages as a lung immunotherapeutic strategy against Pseudomonas aeruginosa infections.
Kheir S; Villeret B; Garcia-Verdugo I; Sallenave JM
Mol Ther; 2022 Jan; 30(1):355-369. PubMed ID: 34371178
[TBL] [Abstract][Full Text] [Related]
17. Pathophysiological changes induced by Pseudomonas aeruginosa infection are involved in MMP-12 and MMP-13 upregulation in human carcinoma epithelial cells and a pneumonia mouse model.
Park JW; Shin IS; Ha UH; Oh SR; Kim JH; Ahn KS
Infect Immun; 2015 Dec; 83(12):4791-9. PubMed ID: 26438797
[TBL] [Abstract][Full Text] [Related]
18. Inflammation as a Modulator of Host Susceptibility to Pulmonary Influenza, Pneumococcal, and Co-Infections.
Aguilera ER; Lenz LL
Front Immunol; 2020; 11():105. PubMed ID: 32117259
[TBL] [Abstract][Full Text] [Related]
19. Influenza A virus activates cellular Tropomyosin receptor kinase A (TrkA) signaling to promote viral replication and lung inflammation.
Verma V; Dileepan M; Huang Q; Phan T; Hu WS; Ly H; Liang Y
PLoS Pathog; 2022 Sep; 18(9):e1010874. PubMed ID: 36121891
[TBL] [Abstract][Full Text] [Related]
20. Hyperactivation of the NLRP3 inflammasome protects mice against influenza A virus infection via IL-1β mediated neutrophil recruitment.
Niu J; Wu S; Chen M; Xu K; Guo Q; Lu A; Zhao L; Sun B; Meng G
Cytokine; 2019 Aug; 120():115-124. PubMed ID: 31055218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
